Page 19 - Revista SPORL - Vol 45. Nº2
P. 19
ESTUDO RETROSPECTIVO COMPARANDO QUIMIOTERAPIA NEOADJUVANTERADIOTERAPIA
COM RADIOTERAPIA ISOLADA EM DOENTES COM CARCINOMA DA NASOFARINGE
NW ryngeal advanced nasopharyngeal carci-
nomo. Concer 83: 22702283, 1998.
AI Sorrof M, LeBIonc M Giri PGS, Fu KK, 7 Cooper JS, Lee H, Torrey M, e' 01: Impro
Cooper J, Vuong T, Forustiere AA, Adams ved outcome secondary to concurrent che-
G, Sari WA, Schullor DE, Ensley JF, moradiotheropy Íor advanced carcinoma
1998, Chemorodiotheropy versus Radio- 01 the nosophoryngx: Preliminary oorrobo
therapy in patients with advanced noso- rotion of the intergroup experience.
phryngeol cancer: phase III randomized lntJ Radiot Oncol Biol Phys 47:
Intergroup Study 0099. J Clin Oncol ló: 861-866, 2000.
1310-1317 8 Cvitkovic E ond the International Noso-
Chan ATC, Teo PML, Leung TWT, Leung pharynx Concer Study Group: Prelimina-
SF, Lee WY, Yoo W, Choi PHK, Johnson ry results of o randomized trial comparing
PJ, 1995, A prospective randomized stu- neoodiuvant chemotherapy (cisplatin,
dy oÍ chemotherapy odiunctive to defini- epirubicin, bloomycin) plus radiotherapy
tive radiotherapy in advanced nasopha- vs. radiotherapy clone in stage IV [>N2,
ryngeal carcinoma. M01 undifterentiated nasopharyngeol cor-
lntJ Rodiot Oncol Biol Phys 33: 569-577 cinomo: A positive effect on progression-
Chcn ATC, Teo PML, Ngon RK, Leung -hee survival. lntJ Radiat Oncol Biol Phys
TWT, leung SF, Lou WH, Zee B, Leung 35: 463-469, 1996.
SF, Cheung FY, Yeo W, Yiu HH, Yu KW, 9 Georg F, Sanguineti G, Tucker 5, et al.
Chan DT, Mok T, Yuen KT, Mo F, Loi M, Carcinoma of the nasophorynx treated by
Kwon WH, Choi P, Johnson PJ, 2002, radiotherapy alone: determinants of dis-
Concurrent chemotherapy—radiotheropy tont metastasis and survival.
compared with radiotherapy alone in |o- Rcdiother Oncol 1997; 43(1): 53-61
coregionolly advanced nosopharyngeol 10 Hcreyoma M, Sokot K, Shirato H, et 01:
carcinoma: progression-h'ee survival ono— A prospective, randomized trial comparing
lysis of a phase III randomized trial. J Clin neoodiuvom chemotherapy with radiothe-
Oncol 20: 2038-2044 ropy oIone in patients with advanced no
Chen WZ, ZhouDl, luo KS: Long term sophcryngeol carcinoma.
observation after radiotherapy for noso- Cancer 94:2217-2223, 2002.
pharyngeal carcinoma (NPC). IntJ Rodiot 1 1 Hong S, Wu HG, Chie EK, Bong YJ, Heo
Oncol Biol Phys 16: 31 1-314, 1989 DS, Kim KH, Sung MW, Pork Cl, 1999,
Chi KH, Chang YC, Guo WY, et ol: A Neoodiuvom chemotherapy ond radiati-
phose ||| study of adjuvant chemotherapy on therapy compared with radiation the-
in advanced nosophoryngeal carcinoma ropy clone in advanced nosophoryngeol
patients. Int J Radiot Oncol Biol Phys carcinoma. lntJ Rodiot Biol Phys 45:
52: 1238—1244, 2002. 901-905
Chuo DTT, Sham JST, Choy D, et ol: Preli— 12 Lee A., PoonY, Foo W, et ol. Retrospec-
mincry report of the AsionOceonic Cli- tive analysis of 5037 patients with noso
nicol Oncology Association randomized pharyngeal carcinoma treated during
trial comparing cisplatin ond epirubicin 19761985: overall survival and patterns
followed by radiotherapy versus radiothe of Failure. Int J Radiant Onc Biol Phys
ropy alone in the treatment of patients 1992; 23; 261-270
with locoregionolly advanced nasopho- 13 Lin JC, Jon JS, Hsu CY, Jiang RS, Wong
